Brainsway is a commercial stage medical device company. Co. is engaged in the development and commercialization of noninvasive neurostimulation products using its Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder, obsessive-compulsive disorder, and smoking addiction. Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. Co.'s technology can increase brain activity in neuronal networks which are hypoactive, or alternatively decrease brain activity in neuronal networks which are hyperactive. Co.'s proprietary electromagnetic coils are designed to stimulate brain regions. The BWAY average annual return since 2019 is shown above.
The Average Annual Return on the BWAY average annual return since 2019 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether BWAY average annual return since 2019 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the BWAY average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|
Free BWAY Email Alerts:
Video: Don't Forget Dividends in Average Annual Return!
